Rhodamine 6G

Rhodamine 6G

SCHEMBL337156

CCN=c1cc2oc3cc(NCC)c(C)cc3c(-c3ccccc3C(=O)OCC)c-2cc1C.[Cl-].[H+]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Rhodamine 6G. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.37
▸ USP2 O75604 2/20 0.36
▸ CFTR P13569 1/20 0.36
▸ PAX8 Q06710 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ GOPC Q9HD26 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ GAA P10253 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ MAPT P10636 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ FTO Q9C0B1 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rhodamine 6G SCHEMBL4817749 0.98 ABCB1 (0.38) ABCB1USP2CFTRPAX8ATM
Rhodamine 6G SCHEMBL10028465 0.98 ABCB1 (0.38) ABCB1USP2CFTRPAX8ATM
Rhodamine 6G SCHEMBL1495836 0.98 ABCB1 (0.38) ABCB1USP2CFTRPAX8ATM
Rhodamine 6G SCHEMBL5606069 0.97 USP2 (0.38) ABCB1USP2CFTRPAX8ATM
Rhodamine 6G SCHEMBL5403477 0.97 USP2 (0.38) ABCB1USP2CFTRPAX8ATM
Rhodamine 6G SCHEMBL23064835 0.97 USP2 (0.38) ABCB1USP2CFTRPAX8ATM
Rhodamine 6G SCHEMBL15348373 0.97 USP2 (0.38) ABCB1USP2CFTRPAX8ATM
Rhodamine 6G SCHEMBL23064834 0.97 USP2 (0.38) ABCB1USP2CFTRPAX8ATM
Rhodamine 6G SCHEMBL58076 0.97 USP2 (0.38) ABCB1USP2CFTRPAX8ATM
Rhodamine 6G SCHEMBL8647391 0.97 USP2 (0.38) ABCB1USP2CFTRPAX8ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030108488-A1 Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants PROCTER & GAMBLE COMPANY, THE 2003-06-12 — — US claimed
CN-122095314-A Photosensitive resin laminate, method for forming resist pattern, and method for manufacturing wiring board having conductor pattern — 2026-05-26 — — CN disclosed
WO-2026100708-A1 PHOTOSENSITIVE RESIN LAMINATE, PHOTOSENSITIVE ELEMENT, AND PATTERN FORMING METHOD 旭化成株式会社 2026-05-15 — — WO disclosed
CN-122029490-A Photosensitive resin laminate, method for forming resist pattern, and method for forming wiring board 旭化成株式会社 2026-05-12 — — CN disclosed
CN-114114841-B Photosensitive resin laminate and method for forming resist pattern 旭化成株式会社 2026-05-12 — — CN disclosed
EP-4726016-A1 ADDITIVE COMPOSITION FOR LUBRICANTS AND METHOD OF USE THEREOF Syensqo Specialty Polymers Italy S.p.A. (IT) 2026-04-15 — — EP disclosed
US-20260098226-A1 ADDITIVE COMPOSITION FOR LUBRICANTS AND METHOD OF USE THEREOF Syensqo Specialty Polymers Italy S.p.A. (IT) 2026-04-09 — — US disclosed
CN-121574722-A Plasma as afterglow excitation source 中国科学院深圳先进技术研究院 2026-02-27 — — CN disclosed
CN-120077329-A Photosensitive resin composition, photosensitive resin laminate, and method for forming resist pattern 旭化成株式会社 2025-05-30 — — CN disclosed
CN-120044756-A Photosensitive resin composition 旭化成株式会社 2025-05-27 — — CN disclosed
US-20030108488-A1 Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants PROCTER & GAMBLE COMPANY, THE 2003-06-12 — — US disclosed
US-20020068293-A1 Arrays having background features and methods for using the same AGILENT TECHNOLOGIES, INC. 2002-06-06 — — US disclosed
US-20020051973-A1 TECHNIQUES FOR ASSESSING NONSPECIFIC BINDING OF NUCLEIC ACIDS TO SURFACES AGILENT TECHNOLOGIES, INC. 2002-05-02 — — US disclosed
US-6335531-B1 Modification of resist and/or resist processing with fluorescence detection MICRON TECHNOLOGY, INC. 2002-01-01 — — US disclosed
US-5741662-A Direct stain specific binding assays for microorganisms QUIDEL CORPORATION (US) 1998-04-21 — — US disclosed
WO-1997022714-A1 DIRECT STAIN SPECIFIC BINDING ASSAYS FOR MICROORGANISMS QUIDEL CORPORATION (US) 1997-06-26 — — WO disclosed
US-4824827-A DYE, PROTON DONOR S. C. JOHNSON & SON, INC. (US) 1989-04-25 — — US disclosed
EP-0309173-A2 Time-color indicators S.C. JOHNSON & SON, INC. (US) 1989-03-29 — — EP disclosed
EP-0093337-B1 PHOTOGRAPHIC REGISTRATION PROCESS Agfa-Gevaert AG (DE) 1985-12-04 — — EP disclosed
US-4543308-A EXPOSURE AND DEVELOPMENT OF PHOTOSENSITIVE LAYER CONTAINING SILVER HALIDE EMULSION AND LUMINESCENCE COMPOUND, SCANNING AND ELECTRICSL AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) 1985-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030108488-A1 Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants TAS2R10, TAS1R1, TAS2R40 ABCB1 2085/4885USP2 4290/4885CFTR 1197/4885
US-20260098226-A1 ADDITIVE COMPOSITION FOR LUBRICANTS AND METHOD OF USE THEREOF FGB, PF4, GFRA1 ABCB1 435/4885USP2 4269/4885CFTR 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback